Fig. 2From: High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancerQuantification of immunostaining for p62, LC3, and NRF2 in pancreatic tumors. Scatter plots showing the immunohistochemical staining scores (staining intensity × percentage of positive tumor cells). Lines indicate means, and circles represent individual patientsBack to article page